SCHEMBL20866716

SCHEMBL20866716

N=C(NC1N=C(c2ccccc2)c2ccccc2NC1=O)SC(=N)c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 15/20 0.63
▸ CCKAR P32238 10/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20866671 0.94 CCKBR (0.59) CCKBRCCKAR
SCHEMBL20866824 0.93 CCKBR (0.71) CCKBRCCKAR
SCHEMBL20867025 0.90 CCKBR (0.73) CCKBRCCKAR
SCHEMBL20098490 0.85 CCKBR (0.66) CCKBRCCKAR
SCHEMBL642047 0.82 CCKBR (0.91) CCKBRCCKAR
SCHEMBL20866597 0.81 CCKBR (0.65) CCKBRCCKAR
SCHEMBL24611887 0.81 CCKBR (0.61) CCKBRCCKAR
SCHEMBL20866819 0.80 CCKBR (0.63) CCKBRCCKAR
SCHEMBL24490741 0.80 CCKBR (0.72) CCKBRCCKAR
SCHEMBL2930364 0.80 CCKBR (0.76) CCKBRCCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3324977-B1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARM INC (US) 2022-07-13 — — EP disclosed
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback